Evidence map›Paper›PMID 24381728›Full record

ReviewF1000prime reports2013

The rise of the Type VI secretion system.

Alain Filloux

Open access · bronzeAbstract readReview
In one paragraph

Review in F1000prime reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Genome sequence of bacteriophage GiJojo, isolated usingMicrobiology resource announcements · 2024
    Article
  2. Article
  3. The Anti-Listeria Activity ofPathogens (Basel, Switzerland) · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Insecticidal Toxicity ofFrontiers in cellular and infection microbiology · 2018
    Article
  14. Article
  15. Identification of New Virulence Factors and Vaccine Candidates forFrontiers in cellular and infection microbiology · 2017
    Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Alain FillouxImperial College London, Department of Life Sciences, MRC Centre for Molecular Bacteriology and Infection South Kensington Campus, Flowers Building, London SW7 2AZ UK.
Imperial College London · GB

Funding

Medical Research Council MR/J006874/1Medical Research Council MR/K001930/1
6 · The paper itself

Abstract

Bacterial cells have developed multiple strategies to communicate with their surrounding environment. The intracellular compartment is separated from the milieu by a relatively impermeable cell envelope through which small molecules can passively diffuse, while larger macromolecules, such as proteins, can be actively transported. In Gram-negative bacteria, the cell envelope is a double membrane, which houses several supramolecular protein complexes that facilitate the trafficking of molecules. For example, bacterial pathogens use these types of machines to deliver toxins into target eukaryotic host cells, thus subverting host cellular functions. Six different types of nanomachines, called Type I - Type VI secretion systems (T1SS - T6SS), can be readily identified by their composition and mode of action. A remarkable feature of these protein secretion systems is their similarity to systems with other biological functions, such as motility or the exchange of genetic material. The T6SS has provided a refreshing view on this concept since it shares similarity with the puncturing device of bacteriophages, which is used by these viruses to inject their DNA into bacterial target cells. In contrast, the bacterial T6SS transports toxins into other bacteria, engaging a ferocious competition for the colonization of their environment. Moreover, as with few other secretion systems, the T6SS is capable of injecting toxins into eukaryotic cells, which contributes to a successful infection. This highlights the multifunctional aspects of the T6SS, and our understanding of its mechanistic details is an intense field of investigation with significant implications for ecology, agriculture and medicine.

Identifiers

PMID24381728
PMCPMC3854691
OpenAlexW2103891603

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.